Back to Journals » Vascular Health and Risk Management » Volume 5

The management of gestational diabetes

Authors Cheung W

Published 15 January 2009 Volume 2009:5 Pages 153—164


Review by Single-blind

Peer reviewer comments 2

N Wah Cheung

Centre for Diabetes and Endocrinology Research, Westmead Hospital, and University of Sydney, NSW, Australia

Abstract: The incidence of gestational diabetes is increasing. As gestational diabetes is associated with adverse pregnancy outcomes, and has long-term implications for both mother and child, it is important that it is recognized and appropriately managed. This review will examine the pharmacological options for the management of gestational diabetes, as well as the evidence for blood glucose monitoring, dietary and exercise therapy. The medical management of gestational diabetes is still evolving, and recent randomized controlled trials have added considerably to our knowledge in this area. As insulin therapy is effective and safe, it is considered the gold standard of pharmacotherapy for gestational diabetes, against which other treatments have been compared. The current experience is that the short acting insulin analogs lispro and aspart are safe, but there are only limited data to support the use of long acting insulin analogs. There are randomized controlled trials which have demonstrated efficacy of the oral agents glyburide and metformin. Whilst short-term data have not demonstrated adverse effects of glyburide and metformin on the fetus, and they are increasingly being used in pregnancy, there remain long-term concerns regarding their potential for harm.

Keywords: gestational diabetes, insulin, oral antidiabetic agents, pregnancy, type 2 diabetes

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Treatment of congenital fibrinogen deficiency: overview and recent findings

Konstantinos Tziomalos, Sofia Vakalopoulou, Vassilios Perifanis, et al

Vascular Health and Risk Management 2009, 5:843-848

Published Date: 5 October 2009

Ankle Brachial Pressure Index (ABPI): An update for practitioners

Mo Al-Qaisi, David M Nott, David H King, et al

Vascular Health and Risk Management 2009, 5:833-841

Published Date: 30 September 2009

Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice

Cláudia Maria Vilas Freire, Antonio Luiz Pinho Ribeiro, Felipe Batista Lima Barbosa, et al

Vascular Health and Risk Management 2009, 5:811-817

Published Date: 24 September 2009

The role of insulin detemir in overweight type 2 diabetes management

Yared N Demssie, Naveed Younis, Handrean Soran

Vascular Health and Risk Management 2009, 5:553-560

Published Date: 29 June 2009

Treatment of pediatric pulmonary hypertension

Amy Hawkins, Robert Tulloh

Vascular Health and Risk Management 2009, 5:509-524

Published Date: 3 June 2009

Safety and efficacy of alteplase in the treatment of acute ischemic stroke

Giuseppe Micieli, Simona Marcheselli, Piera Angela Tosi

Vascular Health and Risk Management 2009, 5:397-409

Published Date: 8 May 2009

Arterial stiffness in insulin resistance: The role of nitric oxide and angiotensin II receptors

Divina G Brillante, Anthony J O’Sullivan, Laurence G Howes

Vascular Health and Risk Management 2009, 5:73-78

Published Date: 4 December 2008

Relationship between blood pressure levels and adherence to medication in patients with chronic heart failure: How come?

Mahsa Mohammadi, Inger Ekman, Maria Schaufelberger

Vascular Health and Risk Management 2009, 5:13-19

Published Date: 2 December 2008

Current management of type B aortic dissection

T Paul Tran, Ali Khoynezhad

Vascular Health and Risk Management 2009, 5:53-63

Published Date: 10 October 2008